Androgen receptor polymorphism, testosterone levels, and prognosis in patients with acute myocardial infarction

Anne Wang1, John Flanagan2, Stefan Arver2

  • 1Cardiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm 171 76, Sweden.

Insights

Investigating CAG repeat length in the androgen receptor gene and testosterone levels after myocardial infarction (MI) revealed no association with cardiovascular prognosis in men. This finding impacts understanding of testosterone

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Genetics

Background:

  • Low testosterone is linked to cardiovascular disease in men, but findings are inconsistent.
  • Androgen receptor gene polymorphisms, like CAG repeat length, may influence testosterone's effects.
  • Understanding these relationships is crucial for managing cardiovascular risk in men.

Purpose of the Study:

  • To examine CAG repeat length and testosterone levels in men post-myocardial infarction (MI).
  • To analyze the association between CAG repeat length and cardiovascular outcomes.
  • To clarify the role of androgen receptor gene variations in male cardiovascular health.

Main Methods:

  • 122 male patients admitted for acute MI were studied.
  • Testosterone levels were measured at four time points post-MI.
  • Cox regression analyses assessed CAG repeat length in relation to cardiovascular events and mortality over a median of 11.6 years.

Main Results:

  • No significant difference in testosterone levels was observed based on CAG repeat length.
  • CAG repeat length, as a continuous or categorical variable, showed no association with cardiovascular events.
  • While initially linked to all-cause mortality, this association disappeared after age adjustment.

Conclusions:

  • CAG repeat length is not associated with testosterone levels in men following acute MI.
  • Androgen receptor CAG repeat length does not appear to influence cardiovascular prognosis in this cohort.
  • Further research may be needed to fully elucidate the complex interplay between testosterone, genetics, and cardiovascular health.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
320
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
210
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
42
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14